Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial
Title:
Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial
Author:
Bagot, Martine Kim, Youn Zinzani, Pier Luigi Dalle, Stephane Beylot-Barry, Marie Ortiz-Romero, Pablo L Cambalia, Andrea Dereure, Olivier Mortier, Laurent Jacobsen, Eric Battistella, Maxime Gru, Alejandro Moins-Teisserenc, Hélène Paiva, Christine Boyer-Chammard, Agnès Rotolo, Federico Azim, Hatem A. Porcu, Pierluigi